Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jan Zigmond"'
Autor:
Denisa Kanokova, Roman Matejka, Margit Zaloudkova, Jan Zigmond, Monika Supova, Jana Matejkova
Publikováno v:
Gels, Vol 10, Iss 5, p 316 (2024)
The bioprinting of high-concentrated collagen bioinks is a promising technology for tissue engineering and regenerative medicine. Collagen is a widely used biomaterial for bioprinting because of its natural abundance in the extracellular matrix of ma
Externí odkaz:
https://doaj.org/article/ede739b8f44d4e9c8dcdcd75aa9cc8c4
Autor:
Jan Zigmond, Ales Tichopad
Publikováno v:
2022 E-Health and Bioengineering Conference (EHB).
Autor:
Marko Hawlina, Lea Kovač, Katarína Breciková, Jan Žigmond, Vladimír Rogalewicz, Aleš Tichopád, Martin Višňanský, Ivana Šarkanová
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-6 (2024)
Abstract Introduction Leber hereditary optic neuropathy (LHON) is the most commonly diagnosed mitochondrial disorder, resulting in colour vision abnormalities and rapid but painless deterioration of central vision. While numerous studies have assesse
Externí odkaz:
https://doaj.org/article/8ea025008bdc4ded9fadf8de8806f496
Autor:
Patrik Palacka, Monika Polanova, Alena Svobodova, Jan Zigmond, Katarina Zanchetta, Vlasta Gombarova, Martina Vulganova, Jan Slopovsky, Jana Obertova, Michal Mego, Lubos Drgona, Juraj Pechan
Publikováno v:
Journal of Clinical Oncology. 40:e18774-e18774
e18774 Background: Vaccination remains the leading strategy against Covid-19 worldwide. BNT 162b2 (tozinameran) belongs among first licensed vaccines with good efficacy. However, the role of monitoring both, antibodies and cell immunity after vaccina
Autor:
Beáta Bušányová, Marie Vajter, Silvie Kelifová, Petra Lišková, Hedviga Miková, Katarína Breciková, Ján Žigmond, Vladimír Rogalewicz, Aleš Tichopád, Martin Višňanský, Ivana Šarkanová
Publikováno v:
Heliyon, Vol 10, Iss 11, Pp e32296- (2024)
Introduction: Leber hereditary optic neuropathy (LHON) is the most frequent mitochondrial disease causing dyschromatopsia and progressive central visual loss that is subacute in progression and painless. Several studies have been published assessing
Externí odkaz:
https://doaj.org/article/a383b506179947b98a424fe25b777414
Autor:
Aleš Tichopád, Jan Žigmond, Miloš Jeseňák, Ivan Solovič, Katarína Breciková, Marian Rybář, Martin Rožánek, Vratislav Sedlák
Publikováno v:
BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)
Background Inhaled corticosteroids have been widely reported as a preventive measure against the development of severe forms of COVID-19 not only in patients with asthma.Methods In 654 Czech and Slovak patients with asthma who developed COVID-19, we
Externí odkaz:
https://doaj.org/article/c4bc5b402915481f953b333546123cad
Autor:
Jan Zigmond, Barbora Novotna, Jaromir Zatloukal, Martin Blazek, Viktor Kasak, Vladimir Koblizek, Ales Tichopad, Jan Chlumsky, Ladislav Pecen
Publikováno v:
5.1 Airway Pharmacology and Treatment.
Background: The Czech Pneumological and Phthisiological Society (CPPS) established (2013) national guidelines based on simultaneous use of GOLD principles and COPD phenotypes. The real implementation of this into routine practice of respiratory speci
Publikováno v:
Open Forum Infectious Diseases. 1:S217-S217
A total of 220 IAI papers were included (47,796 individuals; 4,798 isolates). Complications were reported in 86 studies, severity of infection in 38 studies and mode of acquisition in 173 studies. Overall, Gram-positive bacteria Overall were reported
Autor:
Patrik Palacka, Monika Pol’anová, Alena Svobodová, Jan Žigmond, Katarína Zanchetta, Vlasta Gombárová, Martina Vulganová, Ján Slopovský, Jana Obertová, Ľuboš Drgoňa, Michal Mego, Juraj Pechan
Publikováno v:
Vaccines, Vol 10, Iss 4, p 558 (2022)
Vaccination remains the leading strategy against COVID-19 worldwide. BNT162b2 is among the first licensed vaccines with high effectiveness. However, the role of antibody and cell immunity response monitoring after vaccination remains unclear. We cond
Externí odkaz:
https://doaj.org/article/34779625ae434ebd84a5f67ca6cde37c